Fitzpatrick Alexander A 4
4 · ARS Pharmaceuticals, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Fitzpatrick Alexander A
Chief Legal Officer
Transactions
- Award
Stock option (right to buy)
2023-01-03+700,000→ 700,000 totalExercise: $8.42Exp: 2033-01-02→ Common Stock (700,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on December 1, 2023, and the remaining shares will vest monthly thereafter over three years.